SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-045364
Filing Date
2024-11-05
Accepted
2024-11-05 17:19:10
Documents
82
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bcrx-20240930.htm   iXBRL 10-Q 1598647
2 EX-10.1 biocrystpharmaceuticalsinc.htm EX-10.1 17870
3 EX-31.1 bcrx-20240930xexx311.htm EX-31.1 9620
4 EX-31.2 bcrx-20240930xexx312.htm EX-31.2 9594
5 EX-32.1 bcrx-20240930xexx321.htm EX-32.1 4671
6 EX-32.2 bcrx-20240930xexx322.htm EX-32.2 4645
  Complete submission text file 0001628280-24-045364.txt   8408708

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bcrx-20240930.xsd EX-101.SCH 61648
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bcrx-20240930_cal.xml EX-101.CAL 67721
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bcrx-20240930_def.xml EX-101.DEF 258274
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bcrx-20240930_lab.xml EX-101.LAB 739697
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bcrx-20240930_pre.xml EX-101.PRE 499329
84 EXTRACTED XBRL INSTANCE DOCUMENT bcrx-20240930_htm.xml XML 1220449
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 241428562
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)